Press Releases (-) Any 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2020 September 18, 2020 argenx to Present Additional Data from Global Phase 3 ADAPT Trial of Efgartigimod for Myasthenia Gravis at Upcoming Virtual Medical Meetings September 2, 2020 argenx Management to Present at Upcoming Virtual Investor Conferences August 4, 2020 argenx to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference July 30, 2020 argenx reports half year 2020 financial results and provides second quarter business update July 23, 2020 argenx to report half year 2020 financial results and second quarter business update on July 30, 2020 June 3, 2020 argenx to Present at Goldman Sachs 41st Annual Global Healthcare Conference January 1, 2020 argenx announces closing of global offering May 29, 2020 argenx announces full exercise of underwriters’ option to purchase additional ADSs May 28, 2020 argenx raises $750 million in gross proceeds in a global offering May 26, 2020 argenx announces launch of proposed global offering May 26, 2020 argenx Announces Positive Topline Phase 3 ADAPT Trial Results May 14, 2020 argenx reports first quarter 2020 financial results and provides business update Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
